Back to Search
DAVID TWEARDY, MD
MD
Infectious Disease Physician
NPI: 1720168065IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
L0668(TX)
Education
HARVARD MEDICAL SCHOOL
Class of 1978
Research & Publications (20)
Essential role for platelets in organ injury and inflammation in resuscitated hemorrhagic shock.
PMID 16980886·Shock·2006
7-preclinical
Enhancing or eliminating signals for cell survival to treat disease.
PMID 18528463·Trans Am Clin Climatol Assoc·2006
7-preclinical
SH2 domain binding to phosphopeptide ligands: potential for drug targeting.
PMID 19273114·Front Biosci (Landmark Ed)·2009
6-review
Chemical probes that competitively and selectively inhibit Stat3 activation.
PMID 19274102·PLoS One·2009
8-other
Substance P is required for the pathogenesis of EMCV infection in mice.
PMID 19436834·Int J Clin Exp Med·2009
8-other
Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes.
PMID 19440118·Medicine (Baltimore)·2009
8-other
Prevention of trauma and hemorrhagic shock-mediated liver apoptosis by activation of stat3alpha.
PMID 18997875·Int J Clin Exp Med·2008
8-other
Prevention of hypovolemic circulatory collapse by IL-6 activated Stat3.
PMID 18270592·PLoS One·2008
7-preclinical
Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques.
PMID 18547256·J Med Primatol·2008
7-preclinical
Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
PMID 18576802·J Parasitol·2008
7-preclinical
Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference.
PMID 18643750·J Infect Dis·2008
8-other
T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.
PMID 18615483·Prostate·2008
7-preclinical
Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern.
PMID 17634277·J Leukoc Biol·2007
4-observational
Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.
PMID 17671166·Mol Biol Cell·2007
8-other
Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis.
PMID 17158891·Infect Immun·2007
7-preclinical
Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.
PMID 17855361·J Biol Chem·2007
7-preclinical
Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
PMID 16824611·J Infect·2007
8-other
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.
PMID 16505101·Mol Cancer Ther·2006
7-preclinical
Interleukin-6 treatment reverses apoptosis and blunts susceptibility to intraperitoneal bacterial challenge following hemorrhagic shock.
PMID 16521270·Crit Care Med·2006
7-preclinical
Maternal corticosteroids to prevent intrauterine exposure to hyperthermia and inflammation: a randomized, double-blind, placebo-controlled trial.
PMID 16875647·Am J Obstet Gynecol·2006
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1720168065
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile